TMO

Consider This Before Taking a Position in TMO

Shares of Industrials sector company Thermo Fisher Scientific moved 1.0% today, and are now trading at a price of $487.41. The large-cap stock's daily volume was 1,002,353 compared to its average volume of 1,769,239. The S&P 500 index returned a 0.0% performance.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company is based in Waltham and has 130,000 full time employees. Its market capitalization is $188,321,579,008. Thermo Fisher Scientific currently offers its equity investors a dividend that yields 0.3% per year.

23 analysts are following Thermo Fisher Scientific and have set target prices ranging from $435.0 to $635.0 per share. On average, they have given the company a rating of buy. At today's prices, TMO is trading -7.18% away from its average analyst target price of $525.14 per share.

Over the last year, TMO shares have gone down by -11.0%, which represents a difference of -25.0% when compared to the S&P 500. The stock's 52 week high is $609.85 per share and its 52 week low is $415.6. With average free cash flows of $5.7 Billion that have been growing at an average rate of 7.5% over the last 6 years, Thermo Fisher Scientific declining stock performance may not be reflective of the quality of its underlying business.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 7,693,000 1,839,000 5,854,000 -15.29
2022 9,154,000 2,243,000 6,911,000 1.8
2021 9,312,000 2,523,000 6,789,000 -0.38
2020 8,289,000 1,474,000 6,815,000 68.4
2019 4,973,000 926,000 4,047,000 6.92
2018 4,543,000 758,000 3,785,000
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS